Brief: Puma Biotechnology Q3 Adjusted EPS USD 0.46
07/11/2024 21:05
Nov 07 (Reuters) - Puma Biotechnology Q3 adjusted net income USD 22.4 million. * Q3 net income USD 20.3 million * Q3 EPS USD 0.41 * Q3 product revenue USD 56.1 million
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2